AtriCure, Inc. (ATRC)
-NasdaqGM 9.07 
0.18(1.95%) May 17, 4:00PM EDT
| Prev Close: | 9.25 |
|---|
| Open: | 9.15 |
|---|
| Bid: | 7.12 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 11.40 |
|---|
| Beta: | 0.27 |
|---|
| Next Earnings Date: | 2-Aug-13 |
|---|
| Day's Range: | 8.98 - 9.29 |
|---|
| 52wk Range: | 5.90 - 9.98 |
|---|
| Volume: | 63,104 |
|---|
| Avg Vol (3m): | 83,806 |
|---|
| Market Cap: | 189.84M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.46 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CE Mark for STJ's ILUMIEN OPTISZacks(Fri, May 17)
- Stryker Reiterated at NeutralZacks(Fri, May 17)
- A Contrarian Approach to Investing in Health Care: Expert Portfolio Manager Mark W. Oelschlager Interviews with The Wall Street TranscriptWall Street Transcript(Fri, May 17)
- Covidien Prices Senior NotesZacks(Thu, May 16)
- CE Mark for STJ's Ellipse & AssuraZacks(Mon, May 13)
- Stryker Hits New 52-Week HighZacks(Fri, May 10)
- St. Jude Reiterated at NeutralZacks(Fri, May 10)
- ATRICURE, INC. FinancialsEDGAR Online Financials(Fri, May 10)
- 5 Healthcare Stocks Heading in Different Directions After Earningsat Wall St. Cheat Sheet(Sat, May 4)
- ATRICURE, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 3)
- AtriCure's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 2)
- AtriCure Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Thu, May 2)
- AtriCure, Inc. Earnings Call scheduled for 4:30 pm ET todayCCBN(Thu, May 2)
- AtriCure Reports First Quarter 2013 Financial ResultsBusiness Wire(Thu, May 2)
- ATRICURE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, May 2)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.68 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.42 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.10 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | -1.10 |
|---|
Business Summary
AtriCure, Inc., a medical device company, develops, manufactures, and sells cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue.
View More